相关实验视频

Updated: May 15, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

未来的道路是仿真抗原受体T细胞

Carli M Stewart^1,2,3, Elizabeth L Siegler^1,4, Saad S Kenderian^1,4,5,6

¹T Cell Engineering, Mayo Clinic, Rochester, MN, United States.

Journal of immunology (Baltimore, Md. : 1950)

|April 10, 2025

概括

化学抗原受体T (CART) 细胞疗法对B细胞癌症具有显著的前景. 本综述详细介绍了CART细胞疗法在治疗各种疾病方面的当前挑战和未来方向.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
在瘤学瘤学.

背景情况:

化学抗原受体T (CART) 细胞疗法已经彻底改变了B细胞恶性瘤治疗.
在了解CART细胞治疗的有效性和局限性方面取得了重大进展.

研究的目的:

提供关于CART细胞疗法的当前临床状况的全面概述.
识别和讨论CART细胞治疗中的关键挑战和潜在解决方案.
探索CART细胞治疗的未来轨迹,包括固体瘤和其他疾病.

主要方法:

目前CART细胞治疗研究和临床应用的文献综述.
分析诸如患者获取,毒性,瘤异质性,贩运,微环境和细胞命运等挑战.
讨论所学到的教训,建议的解决方案,以及未来的研究方向.

主要成果:

在B细胞恶性瘤中,CART细胞治疗显示出了显著的长期反应.
关键的挑战包括患者获取,CART相关的毒性,瘤异质性,细胞贩运,瘤微环境和不同的CART细胞命运.
对于每一个挑战,都确定了潜在的解决方案和未来发展领域.

结论:

卡特细胞疗法是一种强大的工具,面临着需要创新解决方案的持续挑战.
该领域正在扩大超越血液恶性瘤,探索固体瘤和其他非癌症疾病.
未来的研究将专注于克服目前的局限性,以扩大工程细胞疗法的应用.

关键词:

自身免疫性疾病是一种自身免疫性疾病.癌症癌症癌症癌症癌症仿制性抗原受体T细胞疗法免疫疗法免疫疗法

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.